BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24078030)

  • 1. Characterization of a unique motif in LIM mineralization protein-1 that interacts with jun activation-domain-binding protein 1.
    Sangadala S; Yoshioka K; Enyo Y; Liu Y; Titus L; Boden SD
    Mol Cell Biochem; 2014 Jan; 385(1-2):145-57. PubMed ID: 24078030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LIM mineralization protein-1 potentiates bone morphogenetic protein responsiveness via a novel interaction with Smurf1 resulting in decreased ubiquitination of Smads.
    Sangadala S; Boden SD; Viggeswarapu M; Liu Y; Titus L
    J Biol Chem; 2006 Jun; 281(25):17212-17219. PubMed ID: 16611643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and optimization of a cell-based assay for the selection of synthetic compounds that potentiate bone morphogenetic protein-2 activity.
    Okada M; Sangadala S; Liu Y; Yoshida M; Reddy BV; Titus L; Boden SD
    Cell Biochem Funct; 2009 Dec; 27(8):526-34. PubMed ID: 19862690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular interaction between Smurf1 WW2 domain and PPXY motifs of Smad1, Smad5, and Smad6--modeling and analysis.
    Sangadala S; Metpally RP; Reddy BV
    J Biomol Struct Dyn; 2007 Aug; 25(1):11-23. PubMed ID: 17676934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling and analysis of molecularinteraction between Smurf1-WW2 domain and various isoforms of LIM mineralization protein.
    Sangadala S; Boden SD; Metpally RP; Reddy BV
    Proteins; 2007 Aug; 68(3):690-701. PubMed ID: 17510966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LIM Mineralization Protein-1 Enhances Bone Morphogenetic Protein-2-Mediated Osteogenesis Through Activation of ERK1/2 MAPK Pathway and Upregulation of Runx2 Transactivity.
    Pan H; Li X; Wang J; Zhang K; Yang H; Li Z; Zheng Z; Liu H
    J Bone Miner Res; 2015 Aug; 30(8):1523-35. PubMed ID: 25677945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Interaction Between Smurfl WW2 Domain and PPXY Motifs of Smadl, Smad5, and Smad6-Modeling and Analysis.
    Sangadala S; Rao Metpally RP; B Reddy BV
    J Biomol Struct Dyn; 2007 Aug; 25(1):11-23. PubMed ID: 22670624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering, cloning, and functional characterization of recombinant LIM mineralization protein-1 containing an N-terminal HIV-derived membrane transduction domain.
    Sangadala S; Okada M; Liu Y; Viggeswarapu M; Titus L; Boden SD
    Protein Expr Purif; 2009 Jun; 65(2):165-73. PubMed ID: 19284982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synthetic compound that potentiates bone morphogenetic protein-2-induced transdifferentiation of myoblasts into the osteoblastic phenotype.
    Kato S; Sangadala S; Tomita K; Titus L; Boden SD
    Mol Cell Biochem; 2011 Mar; 349(1-2):97-106. PubMed ID: 21110071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jun activation domain-binding protein 1 binds Smad5 and inhibits bone morphogenetic protein signaling.
    Haag J; Aigner T
    Arthritis Rheum; 2006 Dec; 54(12):3878-84. PubMed ID: 17133595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12.
    Nishimura R; Kato Y; Chen D; Harris SE; Mundy GR; Yoneda T
    J Biol Chem; 1998 Jan; 273(4):1872-9. PubMed ID: 9442019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
    Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
    Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of BMPs/Smad signaling pathway in mechanical response in osteoblasts.
    Wang L; Zhang X; Guo Y; Chen X; Li R; Liu L; Shi C; Guo C; Zhang Y
    Cell Physiol Biochem; 2010; 26(6):1093-102. PubMed ID: 21220940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1-induced Runx2 degradation.
    Shen R; Chen M; Wang YJ; Kaneki H; Xing L; O'keefe RJ; Chen D
    J Biol Chem; 2006 Feb; 281(6):3569-76. PubMed ID: 16299379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling.
    Yan X; Liao H; Cheng M; Shi X; Lin X; Feng XH; Chen YG
    J Biol Chem; 2016 Jan; 291(1):382-92. PubMed ID: 26555259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Truncated human LMP-1 triggers differentiation of C2C12 cells to an osteoblastic phenotype in vitro.
    Fei Q; Boden SD; Sangadala S; Viggeswarapu M; Liu Y; Titus L
    Acta Biochim Biophys Sin (Shanghai); 2007 Sep; 39(9):693-700. PubMed ID: 17805464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells.
    Shackleford TJ; Zhang Q; Tian L; Vu TT; Korapati AL; Baumgartner AM; Le XF; Liao WS; Claret FX
    Breast Cancer Res; 2011 Jun; 13(3):R65. PubMed ID: 21689417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ISSLS prize winner: LMP-1 upregulates intervertebral disc cell production of proteoglycans and BMPs in vitro and in vivo.
    Yoon ST; Park JS; Kim KS; Li J; Attallah-Wasif ES; Hutton WC; Boden SD
    Spine (Phila Pa 1976); 2004 Dec; 29(23):2603-11. PubMed ID: 15564908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-linked intellectual disability gene CUL4B targets Jab1/CSN5 for degradation and regulates bone morphogenetic protein signaling.
    He F; Lu D; Jiang B; Wang Y; Liu Q; Liu Q; Shao C; Li X; Gong Y
    Biochim Biophys Acta; 2013 May; 1832(5):595-605. PubMed ID: 23357576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.